Search

everythinglearnresearchcommunity

for

Search:↓

Kennedy's disease leads to muscle weakness and sensory issues, has no cure but manageable symptoms, and future treatments look promising.

Myo-inositol helps improve skin conditions and metabolic profiles in young women with PCOS.

Androgens are important for normal ovarian function and estrogen production, but may not be the main cause of follicle death.

New findings explain how genetic changes, body clocks, and certain molecules affect tissue response to stress hormones.

Dermatologists play a key role in treating skin symptoms of PCOS like dark patches, excess hair, acne, and hair loss.

Polycystic Ovary Syndrome is linked to higher risk of hypertension and heart disease.

Products should be called 'sperm-safe' only after thorough, well-designed tests.

Hair loss can indicate underlying systemic diseases and addressing these can sometimes reverse the hair loss.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Antidepressants, 5α-reductase inhibitors, and isotretinoin can cause long-lasting sexual dysfunction.

Impaired androgen production in 46,XY DSDs causes ambiguous genitalia and requires long-term care.

Targeting glucocorticoid action might help treat type-2 diabetes, but human trials are needed.

Women with PCOS often have more body hair, acne, and skin darkening, and these signs are linked to metabolic issues like insulin resistance and high cholesterol.

The document concludes that recognizing and properly diagnosing lipodystrophy syndromes is crucial for effective management and treatment.

Minoxidil keeps most hair growth from first year and twice-daily use is better with few side effects.

Using finasteride or dutasteride may cause long-lasting erectile dysfunction.

Women with regular menstrual cycles and PCOS have linked kisspeptin and LH hormone patterns, unlike those with irregular cycles.

Low doses of mixed chemicals cause permanent reproductive malformations in male rats.

The document concludes that future heart disease research should account for sex-specific differences to improve diagnosis, treatment, and outcomes.

A new mutation in the STING protein causes a range of symptoms and its severity may be affected by other genetic variations; treatment with a specific inhibitor showed improvement in one patient.

The document concludes that research on sulfatase inhibitors should continue due to their potential in treating various diseases, despite some clinical trial failures.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Male genital development is driven by androgen signaling and understanding it could help address congenital anomalies.

Gonadal dysgenesis, like Turner's and Klinefelter's syndromes, negatively affects bone health, but hormone treatments can help.

Tumor suppressors help control inflammation in cancer and restoring their function could lead to new treatments.

Accurate diagnosis is key for treating different kinds of hair loss, and immune response variations may affect the condition and treatment results.

Nano-sized plant-based chemicals could improve cervical cancer treatment by being more effective and causing fewer side effects than current methods.

Hormonal therapies are safe and effective for treating adult women's acne.

Inhibitors of 11β-HSD1 show potential for treating type 2 diabetes but require more testing for safety and effectiveness.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.